Keystone Financial Group (Georgia)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.1K Buy
133
+1
+0.8% +$117 0.01% 103
2026
Q1
$15.9K Buy
132
+1
+0.8% +$115 0.01% 107
2025
Q4
$13.9K Buy
131
+2
+2% +$188 0.01% 111
2025
Q3
$11K Hold
129
0.01% 109
2025
Q2
$10.3K Buy
129
+1
+0.8% +$79 0.01% 123
2025
Q1
$10.1K Sell
128
-1,371
-91% -$128K 0.01% 126
2024
Q4
$150K Buy
+1,499
New +$155K 0.12% 70

Other funds holding MRK

Keystone Financial Group (Georgia)'s MRK Position: Q2 2026 in Review

Keystone Financial Group (Georgia) increased its Merck (MRK) stake by 0.76% in Q2 2026, buying an estimated $117 and bringing the position to 133 shares worth $17.1K. The position accounts for 0.01% of the portfolio, ranked #103.

Keystone Financial Group (Georgia) first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $150K in Q4 2024. 1,303 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Keystone Financial Group (Georgia) held 133 shares of Merck worth $17.1K as of Q2 2026.
  • Keystone Financial Group (Georgia) bought 1 Merck share in Q2 2026, an estimated $117.
  • Merck made up 0.01% of Keystone Financial Group (Georgia)'s portfolio in Q2 2026, its #103 holding.
  • Keystone Financial Group (Georgia) first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Keystone Financial Group (Georgia)'s Merck position peaked at $150K in Q4 2024.
  • 1,303 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Keystone Financial Group (Georgia)'s 13F filing for Q2 2026, filed 21 Jul 2026.